rPEG lipids: Risk-free delivery
mRNA active ingredients can help in the treatment of numerous diseases. Evonik paves a reliable way for them to enter the body.
mRNA technology: Facts and figures
Is mRNA technology only used for immune-related diseases? Who are the pioneers in this sector? A market overview.
Progress thanks to the chemical industry
A marathon, not a sprint: In the interview the virologist Prof. Hengel talks about the challenges involved in developing a new vaccine.
Transportation via polymers
Evonik and Stanford University are cooperating in a search for new carrier substances for mRNA vaccines.